Qiagen to Transfer Transplant Dx Rights to Olerup | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen today said that it will transfer distribution rights for the Olerup line of molecular transplantation testing products to LinkMed subsidiary Olerup International on July 1.

The testing products included in the agreement are used for DNA HLA typing. The transfer of assets will include all Olerup SSP HLA sales infrastructure and offices in Austria.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.